Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07192822 · ClinicalTrials.gov registry record · NA

Magic Bowl Virtual Reality Analgesia

A NA study of Pain, Acute, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT07192822 is a NA study of Pain, Acute that has completed, run by University of Washington. The registered enrollment target is 24 participants, below the 101-participant average among 31 other Pain, Acute trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07192822, a NA study of Pain, Acute, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Participants will rate how much pain they experience during several brief thermal stimulations at painful but tolerable temperatures participants pre-approve. During some of the stimuli participants will be in virtual reality, and during some stimuli participants will not be in VR. Sometimes participants will receive two brief stimuli at the same time.

Conditions Studied

Interventions

  • BEHAVIORAL Virtual Reality distraction
  • BEHAVIORAL No Virtual Reality
  • BEHAVIORAL One brief pain stimulus
  • BEHAVIORAL Two simultaneous brief thermal stimuli

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-02-18
Est. Completion 2025-05-29
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT07192822

The ClinicalTrials.gov registry entry for NCT07192822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 31 other Pain, Acute trials with a reported enrollment target (76% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain, Acute appearing as the primary indexed condition, and to 4 interventions - of which Virtual Reality distraction is the first listed.

NCT07192822 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT07192822 about?

NCT07192822 is a clinical study titled "Magic Bowl Virtual Reality Analgesia". Participants will rate how much pain they experience during several brief thermal stimulations at painful but tolerable temperatures participants pre-approve. During some of the stimuli participants will be in virtual reality, and during some stimuli participants will not be in VR. Sometimes partici...

What is the current status of trial NCT07192822?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2025-02-18. Estimated completion is 2025-05-29.

What conditions does trial NCT07192822 study?

This clinical trial studies the following conditions: Pain, Acute.

What interventions are being tested in trial NCT07192822?

The interventions under investigation include: Virtual Reality distraction (BEHAVIORAL), No Virtual Reality (BEHAVIORAL), One brief pain stimulus (BEHAVIORAL), Two simultaneous brief thermal stimuli (BEHAVIORAL).

Who is sponsoring clinical trial NCT07192822?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07192822 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Acute

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.